Peptide Research Roadmap for Beginners
Beginner roadmap
Peptide research roadmap for beginners.
If you have never worked with research peptides before, the volume of compounds, dose ranges, and protocol designs can feel overwhelming. Here is the simplest possible path through it: how to pick your first compound, how to handle the practical mechanics, and how to scale to multi-compound stacks once the basics are working.
Quick orientation
There is no universal best peptide. The right compound depends on the research endpoint you want to measure. The roadmap below assumes you have a research question first; the compound selection comes second.
01Decide your research category
The Aeternum catalog sorts naturally into five research categories: tissue repair and recovery, metabolic and weight loss, cognitive and nootropic, longevity and anti-aging, and skin and dermal. Each has a focused listicle on the site that ranks the most-studied compounds in that category.
Before browsing individual compound guides, pick the category. Are you investigating tendon healing, lean mass and fat loss, BDNF expression, mitochondrial function, or skin remodeling? The answer determines which compounds to consider and which to ignore.
If your research question spans categories, that is fine — you may end up with a multi-compound stack. But pick one primary category to anchor the protocol so the variables stay manageable.
02Read the cornerstone guide for your top candidate
Every Aeternum compound has a cornerstone research guide covering mechanism, half-life, dose ranges from published studies, reconstitution specifics, storage notes, stack pairings, and citations. Reading the cornerstone guide for your top compound takes 8-10 minutes and gives you the full operational picture.
Pay particular attention to the half-life and dosing window data. The pharmacokinetic profile determines administration frequency, which in turn determines the practical workload of the protocol. A weekly compound is much easier to run than a twice-daily one.
Look at the published dose ranges in animal or human research and decide whether your protocol fits within the studied envelope. Research outside the published range is fine but introduces uncertainty that should be acknowledged in the experimental design.
03Verify the batch COA before ordering
Every Aeternum batch has its Certificate of Analysis published in the public COA library. Look up the compound, check the most recent batch lot, and confirm the mass spectrometry identity, HPLC purity (should be 99%+), and LAL endotoxin results meet your protocol’s requirements.
If your research is in an immune-sensitive area, pay particular attention to the endotoxin number. Levels below 1 EU/mg are acceptable for most research; below 0.1 EU/mg is needed for sensitive immunological work.
The COA process is the single most important quality check in research peptide work. A 99%+ pure batch with low endotoxin is the foundation of clean data; substandard batches confound endpoints in ways that may not become apparent until late in the protocol.
04Read the reconstitution protocol
Lyophilized peptides arrive as a freeze-dried powder. Before any in vitro work, the powder must be dissolved in bacteriostatic water (sterile water with 0.9% benzyl alcohol). The reconstitution master guide walks through the protocol step by step, including the dose-volume math.
The two most common reconstitution errors are using sterile water instead of bacteriostatic water (single-use only, contaminates within days) and shaking the vial instead of swirling (denatures peptide bonds, reduces potency). Read the protocol once before reconstituting your first vial.
Read the reconstitution master guide →
05Run a single-compound protocol first
For your first peptide research protocol, use a single compound. Single-compound protocols give you experience with reconstitution, storage, dosing, and observation without the variable explosion of multi-compound stacks.
Pick the compound from your category that has the most published data and the simplest dosing schedule. For tissue research, this is often BPC-157. For metabolic research, this is often Tesamorelin. For cognitive research, this is often Semax. The cornerstone guides will steer you to the right starting point.
Run the single compound through one full observation window before adding a second compound. The data from this initial protocol will inform whether the addition of a synergist is worthwhile or whether the single-compound effect is sufficient.
06Add a synergist for the second protocol
Once the single-compound protocol is producing reproducible results, add a second compound that targets a parallel mechanism. The peptide stack design guide covers the framework: primary plus synergist plus optional recovery agent.
The most-replicated two-compound stacks are BPC-157 plus TB-500 (tissue repair), CJC-1295 plus Ipamorelin (GH axis), Retatrutide plus Tesamorelin (metabolic), and Semax plus NAD+ (cognitive aging). All four are available as pre-formulated blends or as individual compounds.
Read the peptide stack design master guide →
07Document everything
Maintain a research log that captures: batch lot numbers (cross-referenced to COAs), reconstitution dates and volumes, dose schedules, observation timestamps, and any deviation from the planned protocol. Documentation is the difference between research and anecdote.
When you publish, present at a conference, or simply have a conversation with another researcher about what you found, the documentation is what supports the conclusions. Without it, even strong results become unverifiable.
Common beginner mistakes
- Picking a compound based on hype rather than mechanism fit. Choose for the research question, not for what is currently being marketed.
- Skipping the COA verification step. Even reputable suppliers occasionally produce a batch that does not meet specification — only the published COA tells you whether your specific lot does.
- Using sterile water instead of bacteriostatic water for multi-dose reconstitution. The contamination risk after a few days of multi-dose use is significant.
- Stacking too many compounds at once. Three-compound stacks are the practical upper bound for research designs aiming at clean mechanistic conclusions.
- Inconsistent dosing schedules. Random or skipped doses make the data noisy and hard to interpret.
Frequently asked questions
What's the easiest peptide to start research with?
For tissue or recovery research, BPC-157 has the broadest published literature and simple dosing. For metabolic research, Tesamorelin is FDA-approved with extensive clinical data. For cognitive research, Semax has three decades of Russian and international research. The right starting compound depends on your research question, not on universal ranking.
Do I need a lab to do peptide research?
For in vitro work, yes — proper laboratory facilities are required. For animal research, an IACUC-approved facility is required. For self-experimentation (which is not what Aeternum products are sold for), researchers are responsible for understanding their own jurisdictional requirements.
How long does a typical research protocol run?
Tissue repair protocols typically run 4-12 weeks. Metabolic protocols often run 12-48 weeks to capture body composition changes. Cognitive protocols vary from 4-week BDNF response studies to multi-month aging research. The protocol length should match the time scale on which your endpoint changes are expected to manifest.
What's the most important quality factor when ordering peptides?
Independent third-party COA verification with publicly available data. Without published COAs tied to specific batch lots, there is no way to verify that the material in the vial matches what the label says. This is the single most important quality check in research peptide work.
Can I read all the research papers cited in the guides?
Most are freely accessible through PubMed (links provided in the guides). Some require institutional access through a university or research organization. Direct access to source research is essential for protocol decisions where exact dose, frequency, or measurement methods matter.
References
- Sikiric P, Seiwerth S, Rucman R, et al. (2018). Stable Gastric Pentadecapeptide BPC 157 in the Treatment of Colitis. View source
- Akers MJ (2014). Sterile Drug Products: Formulation, Packaging, Manufacturing and Quality. View source
- Manning MC, Chou DK, Murphy BM, et al. (2010). Stability of protein pharmaceuticals: an update. View source
Reviewed by
The Aeternum Labs Research Team
Compounds, COAs, and protocol design
Aeternum Labs verifies every batch in our library against published purity standards. Beginner roadmaps and master guides are written from cumulative experience helping researchers across the catalog.
Research Disclaimer. All compounds discussed in this article are sold by Aeternum Labs for in vitro laboratory research purposes only. They are not intended for human or animal consumption, diagnosis, treatment, or prevention of any disease or condition. Information presented is summarized from publicly available scientific literature and should not be construed as medical advice.